Found 1 results
Filters: Author is D.L. Chen  [Clear All Filters]
H. L. Shuai, Lin, X. Z., Chen, D. L., Li, P., and Luo, X., Association between the PPARγ Pro12Ala polymorphism and risk of gestational diabetes mellitus: a meta-analysis, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSResearch supported by the Guangdong Natural Science Foundation (#2014A030310098) and the Guangdong Medical Scientific Research Foundation (#A2014376). REFERENCESAltshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, et al (2000). The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26: 76-80. Barbour LA, et al (2014). Unresolved controversies in gestational diabetes: implications on maternal and infant health. Curr. Opin. Endocrinol. Diabetes Obes. 21: 264-270. Bottalico JN, et al (2007). Recurrent gestational diabetes: risk factors, diagnosis, management, and implications. Semin. Perinatol. 31: 176-184. Bou M, Todorčević M, Rodríguez J, Capilla E, et al (2014). Interplay of adiponectin, TNFα and insulin on gene expression, glucose uptake and PPARγ, AKT and TOR pathways in rainbow trout cultured adipocytes. Gen. Comp. Endocrinol. 205: 218-225. Campbell IW, et al (2005). The clinical significance of PPAR gamma agonism. Curr. Mol. Med. 5: 349-363. Carolan M, et al (2013). Gestational diabetes mellitus among women born in South East Asia: a review of the evidence. Midwifery 29: 1019-1026. Chawla A, Amundsen AL, Hanssen KF, Iversen PO, et al (2006). [Gestational diabetes in women from South Asia]. Tidsskr. Nor. Laegeforen. 126: 1041-1043. Christodoulides C, Vidal-Puig A, et al (2010). PPARs and adipocyte function. Mol. Cell. Endocrinol. 318: 61-68. Dornhorst A, Paterson CM, Nicholls JS, Wadsworth J, et al (1992). High prevalence of gestational diabetes in women from ethnic minority groups. Diabet. Med. 9: 820-825. Gojnic M, Stefanovic T, Perovic M, Arsic B, et al (2012). Prediction of fetal macrosomia with ultrasound parameters and maternal glycemic controls in gestational diabetes mellitus. Clin. Exp. Obstet. Gynecol. 39: 512-515. Guri AJ, Hontecillas R, Bassaganya-Riera J, et al (2006). Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition. Clin. Nutr. 25: 871-885. Franks PW, Jablonski KA, Delahanty L, Hanson RL, Diabetes Prevention Program Research Groupet al (2007). The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 50: 2451-2460. Jackson D, et al (2013). Confidence intervals for the between-study variance in random effects meta-analysis using generalised Cochran heterogeneity statistics. Res. Synth. Methods 4: 220-229. Jones CW, et al (2001). Gestational diabetes and its impact on the neonate. Neonatal Netw. 20: 17-23. Kim C, Berger DK, Chamany S, et al (2007). Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 30: 1314-1319. Monsalve FA, Pyarasani RD, Delgado-Lopez F, Moore-Carrasco R, et al (2013). Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediators Inflamm. 2013: 549627. Reece EA, Leguizamón G, Wiznitzer A, et al (2009). Gestational diabetes: the need for a common ground. Lancet 373: 1789-1797. Schwartz N, Nachum Z, Green MS, et al (2015). The prevalence of gestational diabetes mellitus recurrence--effect of ethnicity and parity: a metaanalysis. Am. J. Obstet. Gynecol. 213: 310-317. Soares FL, de Oliveira Matoso R, Teixeira LG, Menezes Z, et al (2013). Gluten-free diet reduces adiposity, inflammation and insulin resistance associated with the induction of PPAR-alpha and PPAR-gamma expression. J. Nutr. Biochem. 24: 1105-1111. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, et al (1997). A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 278: 1078-1083. Stang A, et al (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25: 603-605. Tontonoz P, Spiegelman BM, et al (2008). Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77: 289-312. Verier-Mine O, et al (2010). Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review. Diabetes Metab. 36: 595-616. Wang C, Li X, Huang Z, Qian J, et al (2013). Quantitative assessment of the influence of PPARG P12A polymorphism on gestational diabetes mellitus risk. Mol. Biol. Rep. 40: 811-817. Watanabe RM, et al (2011). Inherited destiny? Genetics and gestational diabetes mellitus. Genome Med. 3: 18. WHO (2009). WHO Diabetes Program Country and Regional Data. Available at []. Accessed January 8, 2009. Yan J, Yang H, et al (2014). Gestational diabetes in China: challenges and coping strategies. Lancet Diabetes Endocrinol. 2: 930-931. Yen CJ, Beamer BA, Negri C, Silver K, et al (1997). Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem. Biophys. Res. Commun. 241: 270-274. Zhang C, Bao W, Rong Y, Yang H, et al (2013). Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum. Reprod. Update 19: 376-390.